Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 4—April 2019
Research Letter

Ross River Virus Antibody Prevalence, Fiji Islands, 2013–2015

Maite Aubry, Mike Kama, Jessica Vanhomwegen, Anita Teissier, Teheipuaura Mariteragi-Helle, Stephane Hue, Martin L. Hibberd, Jean-Claude Manuguerra, Ketan Christi, Conall H. Watson, Eric J. Nilles, Colleen L. Lau, John Aaskov, Didier Musso, Adam J. Kucharski, and Van-Mai Cao-LormeauComments to Author 
Author affiliations: Institut Louis Malardé, Papeete, French Polynesia (M. Aubry, A. Teissier, T. Mariteragi-Helle, D. Musso, V.-M. Cao-Lormeau); Fiji Centre for Communicable Disease Control, Suva, Fiji (M. Kama); The University of the South Pacific, Suva (M. Kama, K. Christi); Institut Pasteur, Paris, France (J. Vanhomwegen, J.-C. Manuguerra); London School of Hygiene and Tropical Medicine, London, UK (S. Hue, M.L. Hibberd, C.H. Watson, A.J. Kucharski); World Health Organization Division of Pacific Technical Support, Suva (E.J. Nilles); Harvard Medical School and Brigham and Women’s Hospital, Boston, Massachusetts, USA (E.J. Nilles); Harvard Humanitarian Initiative, Cambridge, Massachusetts (E.J. Nilles); Queensland University of Technology, Brisbane, Queensland, Australia (J. Aaskov); Australian National University, Canberra, Australian Capital Territory, Australia (C.L. Lau); Aix Marseille Université, IRD, AP-HM, SSA, VITROME, IHU-Méditerranée Infection, Marseille, France (D. Musso)

Main Article

Table

Prevalence of Ross River virus antibodies in a representative subset of the population of Fiji sampled during September–November 2013 (n = 778) and October–November 2015 (n = 333)*

Variable No. seropositive/mo. tested (% [95% CI])
2013 2015
Birth year
<1982 197/336 (58.6 [53.4–63.9]) 68/144 (47.2 [39.6–55.7])
>1982 165/441 (37.4 [32.9–42.1]) 56/189 (29.6 [23.2–36.7])
1982–1990 58/117 (49.6 [41.1–58.9]) 17/38 (44.7 [31.4–61.4)
1991–2000 66/146 (45.2 [37.7–53.6]) 20/66 (30.3 [21.3–42.9])
2001–2010 40/170 (23.5 [18.1–30.7]) 19/83 (22.9 [15.8–33.5])
>2011
 1/8 (12.5 [0.3–52.7])
 0/2 (0.0 [0.0–84.2])
Sex
F 195/423 (46.1 [41.5–51.0]) 73/190 (38.4 [32.1–45.8])
M
 167/354 (47.5 [42.2–52.5])
 51/143 (35.7 [28.6–44.1])
Division
Central 172/451 (38.1 [33.9–42.8]) 124/333 (37.2 [32.4–42.7])
Northern 33/59 (55.9 [44.1–68.7]) ND
Western
 157/268 (58.6 [52.8–64.5])
 ND
Zone
Rural 189/344 (54.9 [49.8–60.3]) 52/113 (46.0 [37.5–55.6])
Periurban 55/135 (40.7 [33.2–49.5]) 27/77 (35.1 [26.0–46.8])
Urban
 117/298 (39.3 [34.1–45.1])
 45/143 (31.5 [24.8–39.8])
Total 362/778† (46.5 [43.1–50.1]) 124/333 (37.2 [32.4–42.7])

*ND, no data (participants were not recruited from the Northern and Western divisions in 2015).
†For 1 participant, information about age and sex were not available; for another participant, information about the zone of residence was not available.

Main Article

Page created: March 17, 2019
Page updated: March 17, 2019
Page reviewed: March 17, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external